Ex vivo assays for Hematologic Malignancies
Vivia has overcome shortcomings of >20 years measuring drug
sensitivity in patient samples
sensitivity in patient samples
- Automation capable of measuring up to 2,000 points per sample, and substantially lowering errors.
- Selective evaluation of drug effects on cancer cell subpopulations.
- Measuring of % live cells, not apoptotic
- Maintaining the microenvironment by using whole samples without isolating leukocytes, avoiding artifacts.
- Advanced graphical and visualization tools for results analysis through TIBCO Spotfire® Software. See Online Demo
- Analyzing data by PKPD Population Models that fit dose responses for all samples simultaneously increasing accuracy.
- Including kinetic activity
- Access to AML, MM, CLL, ALL and NHL samples and a large collection of cryopreserved samples.
